Fertility preservation in female classic galactosemia patients

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Van Erven, Britt ^a,b   Gubbels, Cynthia S ^a,c   Van Golde, Ron J ^a,b   Dunselman, Gerard A ^a,b   Derhaag, Josien G ^a,b   De Wert, Guido ^b,d   Geraedts, Joep P ^a,b   Bosch, Annet M ^e   Treacy, Eileen P ^f   Welt, Corrine K ^g   Berry, Gerard T ^c   Rubio Gozalbo, M Estela ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Classic galactosemia; Cryopreservation; Fertility preservation; GALT deficiency; POI; Primary ovarian insufficiency

Indexed keywords

ADULT; CLASSIC GALACTOSEMIA; CONCEPTION; COUNSELING; CRYOPRESERVATION; FEMALE; GALACTOSEMIA; HUMAN; HUMAN TISSUE; KNOWLEDGE; OVARIAN RESERVE; OVARY; PARTHENOGENESIS; PHYSICIAN; PREMATURE OVARIAN FAILURE; REPRODUCTIVE PROCEDURE; RESEARCH ETHICS; REVIEW;

CRYOPRESERVATION; FEMALE; FERTILITY; FERTILITY PRESERVATION; GALACTOSEMIAS; HUMANS; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84880116338     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-107     Document Type: Review

References (68)

1. Ovarian function in girls and women with GALT-deficiency galactosemia. Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E, J Inherit Metab Dis 2011 34 357 366 10.1007/s10545-010-9221-4 20978943
2. Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment. Coss KP, Doran PP, Owoeye C, Codd MB, Hamid N, Mayne PD, Crushell E, Knerr I, Monavari AA, Treacy EP, J Inherit Metab Dis 2012 36 21 27 22870861
3. Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia. Berry GT, Elsas LJ, J Inherit Metab Dis 2011 34 249 255 10.1007/s10545-010-9232-1 21116719
4. Living with classical galactosemia: health-related quality of life consequences. Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HS, Wijburg FA, Last BF, Pediatrics 2004 113 423 e428 10.1542/peds.113.5.e423 15121984
5. A strategy for fertility services for survivors of childhood cancer. Multidisciplinary Working Group convened by the British Fertility Society, Hum Fertil (Camb) 2003 6 1 A39
6. Fertility preservation and reproduction in cancer patients. Ethics Committee of the American Society for Reproductive Medicine, Fertil Steril 2005 83 1622 1628 15950628
7. American Society of Clinical Oncology: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, J Clin Oncol 2006 24 2917 2931 10.1200/JCO.2006.06.5888 16651642 (Pubitemid 46655598)
8. Preservation of fertility in patients with cancer. Jeruss JS, Woodruff TK, N Engl J Med 2009 360 902 911 10.1056/NEJMra0801454 19246362
9. Adolescent and young adult oncology. Clinical practice guidelines in oncology. Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, et al. J Natl Compr Canc Netw 2012 10 1112 1150 22956810
10. [National guideline 'Cryopreservation of ovarian tissue']. Heineman MJ, Beerendonk CC, Kaandorp CJ, Ned Tijdschr Geneeskd 2008 152 2452 2455 19051796
11. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD, Science 1981 214 1145 1147 10.1126/science.7302587 7302587 (Pubitemid 12176630)
12. Galactosemia, a single gene disorder with epigenetic consequences. Coman DJ, Murray DW, Byrne JC, Rudd PM, Bagaglia PM, Doran PD, Treacy EP, Pediatr Res 2010 67 286 292 10.1203/PDR.0b013e3181cbd542 19952866
13. Insights into the pathogenesis of galactosemia. Leslie ND, Annu Rev Nutr 2003 23 59 80 10.1146/annurev.nutr.23.011702.073135 12704219 (Pubitemid 37059716)
14. Gonadal function in male and female patients with classic galactosemia. Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK, Land JA, Hum Reprod Update 2010 16 177 188 10.1093/humupd/dmp038 19793842
15. Clinical practice. Primary ovarian insufficiency. Nelson LM, N Engl J Med 2009 360 606 614 10.1056/NEJMcp0808697 19196677
16. Pathophysiology of impaired ovarian function in galactosaemia. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P, Hum Reprod Update 2006 12 573 584 10.1093/humupd/dml031 16835432 (Pubitemid 44307834)
17. Galactose metabolism and ovarian toxicity. Liu G, Hale GE, Hughes CL, Reprod Toxicol 2000 14 377 384 10.1016/S0890-6238(00)00096-4 11020650
18. [Premature ovarian failure in galactosaemia: pathophysiology and clinical management]. Forges T, Monnier-Barbarino P, Pathol Biol (Paris) 2003 51 47 56 10.1016/S0369-8114(02)00002-0 (Pubitemid 36372025)
19. Reproductive effects of maternal metabolic disorders: implications for pediatrics and obstetrics. Levy HL, Turk J Pediatr 1996 38 335 344 8827903 (Pubitemid 126537730)
20. Ovarian failure in galactosemia. Levy HL, Driscoll SG, Porensky RS, Wender DF, N Engl J Med 1984 310 50 6689743
21. Hypergonadotropic hypogonadism in female patients with galactosemia. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R, N Engl J Med 1981 304 994 998 10.1056/NEJM198104233041702 6782485 (Pubitemid 11156606)
22. [Ovarian insufficiency in congenital galactosemia]. Beauvais P, Guilhaume A, Presse Med 1984 13 2685 2687 6240032
23. Ovarian failure in a young woman with galactosaemia. Morrow RJ, Atkinson AB, Carson DJ, Carson NA, Sloan JM, Traub AI, Ulster Med J 1985 54 218 220 4095816 (Pubitemid 16185065)
24. Hypergonadotrophic hypogonadism in classical galactosaemia: evidence for defective oogenesis Case report. Robinson AC, Dockeray CJ, Cullen MJ, Sweeney EC, Br J Obstet Gynaecol 1984 91 199 200 10.1111/j.1471-0528.1984.tb05908.x 6421309 (Pubitemid 14181957)
25. Feminization in a galactosemic girl in the presence of hypergonadotropic hypogonadism. Schwarz HP, Zimmermann A, Carasso A, Zuppinger K, Acta Endocrinol 1986 279 Suppl (Copenh) 428 433 (Pubitemid 17170032)
26. Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Fraser IS, Russell P, Greco S, Robertson DM, Clin Reprod Fertil 1986 4 133 138 3091236 (Pubitemid 17172187)
27. Primary ovarian insufficiency in classic galactosemia: role of FSH dysfunction and timing of the lesion. Gubbels CS, Land JA, Evers JL, Bierau J, Menheere PP, Robben SG, Rubio-Gozalbo ME, J Inherit Metab Dis 2013 36 29 34 10.1007/s10545-012-9497-7 22729817
28. Pregnancy after oocyte donation to a woman with ovarian failure and classical galactosemia. Sauer MV, Kaufman FR, Paulson RJ, Lobo RA, Fertil Steril 1991 55 1197 1199 2037114
29. [Ovarian insufficiency and galactosemia ]. Dessart Y, Odievre M, Evain D, Chaussain JL, Arch Fr Pediatr 1982 39 321 322 7125830
30. Ovarian failure in galactosaemia. Hoefnagel D, Wurster-Hill D, Child EL, Lancet 1979 2 1197 91933
31. Pregnancy in classic galactosemia despite undetectable anti-Mullerian hormone. Gubbels CS, Kuppens SM, Bakker JA, Konings CJ, Wodzig KW, Der Velden MG DS-v, Menheere PP, Rubio-Gozalbo ME, Fertil Steril 2009 91 1293 e1213 1296
32. Prenatal exposure to high galactose adversely affects initial gonadal pool of germ cells in rats. Bandyopadhyay S, Chakrabarti J, Banerjee S, Pal AK, Bhattacharyya D, Goswami SK, Chakravarty BN, Kabir SN, Hum Reprod 2003 18 276 282 10.1093/humrep/deg058 12571162 (Pubitemid 36236259)
33. Galactose toxicity in the rat as a model for premature ovarian failure: an experimental approach readdressed. Bandyopadhyay S, Chakrabarti J, Banerjee S, Pal AK, Goswami SK, Chakravarty BN, Kabir SN, Hum Reprod 2003 18 2031 2038 10.1093/humrep/deg414 14507817 (Pubitemid 37265062)
34. Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats. Lai KW, Cheng LY, Cheung AL, WS O, Cell Tissue Res 2003 311 417 425 12658449 (Pubitemid 36469298)
35. Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression. Banerjee S, Chakraborty P, Saha P, Bandyopadhyay SA, Banerjee S, Kabir SN, PLoS One 2012 7 30709 10.1371/journal.pone.0030709 22319579
36. Apoptosis in the ovary: molecular mechanisms. Hussein MR, Hum Reprod Update 2005 11 162 177 15705959
37. FSH isoform pattern in classic galactosemia. Gubbels CS, Thomas CM, Wodzig WK, Olthaar AJ, Jaeken J, Sweep FC, Rubio-Gozalbo ME, J Inherit Metab Dis 2011 34 387 390 10.1007/s10545-010-9180-9 20814826
38. Dietary galactose inhibits GDF-9 mediated follicular development in the rat ovary. Liu G, Shi F, Blas-Machado U, Yu R, Davis VL, Foster WG, Magoffin DA, Hughes CL, Reprod Toxicol 2006 21 26 33 10.1016/j.reprotox.2005.07.001 16105726 (Pubitemid 43050922)
39. Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat. Meyer WR, Doyle MB, Grifo JA, Lipetz KJ, Oates PJ, DeCherney AH, Diamond MP, Am J Obstet Gynecol 1992 167 1837 1843 10.1016/0002-9378(92)91784-8 1471707 (Pubitemid 23009333)
40. Galactose inhibition of ovulation in mice. Swartz WJ, Mattison DR, Fertil Steril 1988 49 522 526 3342905 (Pubitemid 18064012)
41. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Gubbels CS, Land JA, Rubio-Gozalbo ME, Obstet Gynecol Surv 2008 63 334 343 10.1097/OGX.0b013e31816ff6c5 18419833 (Pubitemid 351595142)
42. Ovarian tissue cryopreservation and subsequent spontaneous pregnancies in a patient with classic galactosemia. Forges T, Monnier P, Leheup B, Cheillan D, Brivet M, Barbarino A, Gueant JL, Feillet F, Fertil Steril 2011 95 290 e291 293
43. Biochemical monitoring of pregnancy and breast feeding in five patients with classical galactosaemia-and review of the literature. Schadewaldt P, Hammen HW, Kamalanathan L, Wendel U, Schwarz M, Bosch AM, Guion N, Janssen M, Boers GH, Eur J Pediatr 2009 168 721 729 10.1007/s00431-008-0832-9 18813948
44. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Zegers-Hochschild F, Adamson GD, De Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, van der Poel S, International Committee for Monitoring Assisted Reproductive Technology, World Health Organization, Hum Reprod 2009 24 2683 2687 10.1093/humrep/dep343 19801627
45. Undetectable serum anti-Mullerian hormone levels and occurrence of ongoing pregnancy. Fraisse T, Ibecheole V, Streuli I, Bischof P, De Ziegler D, Fertil Steril 2008 89 723 e729 711
46. Recommendations for fertility preservation in patients with lymphomas. Schmidt KT, Andersen CY, Committee IP, J Assist Reprod Genet 2012 29 473 477 10.1007/s10815-012-9787-x 22562284
47. Fertility considerations in young women with hematological malignancies. Jadoul P, Kim SS, Committee IP, J Assist Reprod Genet 2012 29 479 487 10.1007/s10815-012-9792-0 22614159
48. Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Rodriguez-Wallberg KA, Oktay K, Best Pract Res Clin Obstet Gynaecol 2012 26 391 405 10.1016/j.bpobgyn.2012.01.001 22301053
49. Fertility preservation in girls. Michaeli J, Weintraub M, Gross E, Ginosar Y, Ravitsky V, Eizenman E, Mitrani E, Lebovich M, Laufer N, Kennedy S, Revel A, Obstet Gynecol Int 2012 2012 139193 22496695
50. Human oocyte and ovarian tissue cryopreservation and its application. Tao T, Del Valle A, J Assist Reprod Genet 2008 25 287 296 10.1007/s10815-008-9236-z 18670872
51. Cryopreservation of ovarian tissue in pediatric patients. Fabbri R, Vicenti R, Macciocca M, Pasquinelli G, Lima M, Parazza I, Magnani V, Venturoli S, Obstet Gynecol Int 2012 2012 910698 22518166
52. Society for Assisted Reproductive Technology: Mature oocyte cryopreservation: a guideline. Practice Committees of the American Society for Reproductive Medicine, Fertil Steril 2012 99 37 43 23083924
53. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F, Hum Reprod 2010 25 66 73 10.1093/humrep/dep346 19861328
54. Mechanisms of implantation: strategies for successful pregnancy. Cha J, Sun X, Dey SK, Nat Med 2012 18 1754 1767 10.1038/nm.3012 23223073
55. Primary ovarian insufficiency. De Vos M, Devroey P, Fauser BC, Lancet 2010 376 911 921 10.1016/S0140-6736(10)60355-8 20708256
56. Fertility preservation in prepubertal girls prior to chemotherapy and radiotherapy-review of the literature. Lawrenz B, Rothmund R, Neunhoeffer E, Huebner S, Henes M, J Pediatr Adolesc Gynecol 2012 25 284 288 10.1016/j.jpag.2011.05.009 21872516
57. Cryopreservation of ovarian tissue in pediatrics: what is the childs' best interest? Di Pietro ML, Virdis A, Gonzalez-Melado FJ, De Luca D, J Matern Fetal Neonatal Med 2012 25 2145 2148 10.3109/14767058.2012.678430 22489803
58. Ovarian tissue and follicle transplantation as an option for fertility preservation. Grynberg M, Poulain M, Sebag-Peyrelevade S, Le Parco S, Fanchin R, Frydman N, Fertil Steril 2012 97 1260 1268 10.1016/j.fertnstert.2012.04.042 22656306
59. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL, Nat Med 2012 18 413 421 10.1038/nm.2669 22366948
60. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
61. Eshre Task Force on Ethics and Law: Intrafamilial medically assisted reproduction. De Wert G, Dondorp W, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K, Hum Reprod 2011 26 504 509 21247920
62. Using family members as gamete donors or surrogates. Amato P, Brzyski R, Braverman A, Benward J, Stein A, Steinbock B, Wilder B, Reindollar R, Lamb D, Robertson J, et al. Fertil Steril 2012 98 797 803 22835449
63. The neuropsychological profile of galactosaemia. Doyle CM, Channon S, Orlowska D, Lee PJ, J Inherit Metab Dis 2010 33 603 609 10.1007/s10545-010-9154- y 20607611
64. Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia. Hoffmann B, Wendel U, Schweitzer-Krantz S, J Inherit Metab Dis 2011 34 421 427 10.1007/s10545-011-9297-5 21347587
65. The adult galactosemic phenotype. Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, Schomer D, Welt C, Anastasoaie V, et al. J Inherit Metab Dis 2012 35 279 286 10.1007/s10545-011- 9372-y 21779791
66. Remarkable differences: the course of life of young adults with galactosaemia and PKU. Bosch AM, Maurice-Stam H, Wijburg FA, Grootenhuis MA, J Inherit Metab Dis 2009 32 706 712 10.1007/s10545-009-1253-2 19816786
67. Psychosocial developmental milestones in men with classic galactosemia. Gubbels CS, Maurice-Stam H, Berry GT, Bosch AM, Waisbren S, Rubio-Gozalbo ME, Grootenhuis MA, J Inherit Metab Dis 2011 34 415 419 10.1007/s10545-011-9290-z 21350966
68. Longitudinal assessment of intellectual achievement in patients with classical galactosemia. Schadewaldt P, Hoffmann B, Hammen HW, Kamp G, Schweitzer-Krantz S, Wendel U, Pediatrics 2010 125 374 e381 10.1542/peds.2008- 3325 20100763